Loading

Silver Creek Pharmaceuticals

June 04, 2024
Company Presentation
CNS/Neurological
Company Presentation Theater 1
Silver Creek is a clinical-stage biotechnology company headquartered in San Francisco, CA. Our Smart Growth Factor™ technology enables the rapid development of growth factor fusion proteins that are designed to target and heal damaged tissues. Our lead asset, scp776, is a first-in-class, targeted fusion protein that harnesses the cell survival function of IGF-1. Scp776 is currently being evaluated in ARPEGGIO, a Phase II study for the treatment of acute ischemic stroke.
Silver Creek Pharmaceuticals
Company Website: https://silvercreekpharma.com/
Lead Product in Development: scp776

Company HQ City

San Francisco

Company HQ State

CA

Company HQ Country

United States

CEO/Top Company Official

Mark Corrigan, MD

Development Phase of Primary Product

Phase II
Speakers
Kris Kuchenbecker, PhD
Chief Science & Technology Officer
Silver Creek Pharmaceuticals
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS